Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Colorectal Neoplasms 402Rectal Neoplasms 151Colonic Neoplasms 148Pancreatic Neoplasms 111Stomach Neoplasms 106Neoplasm Metastasis 87Neoplasms 74Esophageal Neoplasms 59Small Cell Lung Carcinoma 44Neuroblastoma 42Lung Neoplasms 42Glioblastoma 38Carcinoma, Non-Small-Cell Lung 37Brain Neoplasms 33Esophageal Squamous Cell Carcinoma 32Unspecified Adult Solid Tumor, Protocol Specific 31Glioma 31Breast Neoplasms 28Central Nervous System Neoplasms 27Adenocarcinoma Of Esophagus 27Sarcoma 26Gliosarcoma 22Astrocytoma 22Rhabdomyosarcoma 21Sarcoma, Ewing 18Adenocarcinoma 18Gastrointestinal Neoplasms 17Oligodendroglioma 16Recurrence 13Medulloblastoma 13

Interventions

tipifarnib 1soybean oil, phospholipid emulsion 1penpulimab 1Sunscreening Agents 1Spironolactone 1Sorafenib 1Rifampin 1Morphine 1Methods 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hydrocortisone 1Genetic Testing 1Genetic Counseling 1Fat Emulsions, Intravenous 1Educational Status 1Early Intervention, Educational 1Doxycycline 1Docetaxel 1Counseling 1Cordotomy 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Malignant Neoplasm × Irinotecan × Clear all
NCT06394713 2024-05-01

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
60 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡